California's highest court rules for Gilead in 'duty to innovate' case
|
Court orders dismissal of litigation by estimated 24,000 HIV
patients · Gilead need not face negligence claims for halting development of
alternative ... |
BioNTech Launches mRNA HIV Vaccine Trial
... antiretroviral therapy for at least 12 months will receive four injections. Enrollment will span participants aged 18 to 50 years; those with HIV ... View article...